Evangelos Briasoulis -      1.     Fountzilas G, Dafni U, Gogas H, et al: Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-

Document created by Evangelos Briasoulis on Aug 22, 2014
Version 1Show Document
  • View in full screen mode

  Publication Details (including relevant citation   information): 1. Fountzilas G, Dafni U, Gogas H, et al:   Postoperative dose-dense sequential chemotherapy with epirubicin,   paclitaxel and CMF in patients with high-risk breast cancer:   safety analysis of the Hellenic Cooperative Oncology Group   randomized phase III trial HE 10/00. Ann Oncol 19:853-60, 2008 2.   Fountzilas G, Dafni U, Dimopoulos MA, et al: A randomized phase   III study comparing three anthracycline-free taxane-based   regimens, as first line chemotherapy, in metastatic breast cancer   : A Hellenic Cooperative Oncology Group study. Breast Cancer Res   Treat, 2008 3. Briasoulis E, Ziogas D, Fatouros M: Prophylactic   surgery in the complex decision-making management of BRCA   mutation carriers. Ann Surg Oncol 15:1788-90 4. Briasoulis E,   Roukos DH: Contralateral prophylactic mastectomy: mind the   genetics. J Clin Oncol 26:1909-10 5. Briasoulis E, Pavlidis N,   Felip E: Cancers of unknown primary site: ESMO clinical   recommendation for diagnosis, treatment and follow-up. Ann Oncol   19 Suppl 2:ii106-7, 2008 6. Briasoulis E, Kamposioras K, Tzovaras   V, et al: CENP-B specific anti-centromere autoantibodies   heralding small-cell lung cancer. A case study and review of the   literature. Lung Cancer 60:302-6, 2008 7. Briasoulis E,   Fountzilas G, Bamias A, et al: Multicenter phase-II trial of   irinotecan plus oxaliplatin [IROX regimen] in patients with   poor-prognosis cancer of unknown primary: a hellenic cooperative   oncology group study. Cancer Chemother Pharmacol 62:277-84, 2008   8. Apessos A, Papadopoulou E, Belogianni I, et al: Inherited   cancer predisposition syndromes in Greece. Anticancer Res   28:1341-7, 2008 9. Tzaida O, Gogas H, Dafni U, et al: Evaluation   of the prognostic and predictive value of HER-1/EGFR in breast   cancer patients participating in a randomized study with   dose-dense sequential adjuvant chemotherapy. Oncology 72:388-96,   2007 10. Roukos DH, Murray S, Briasoulis E: Molecular genetic   tools shape a roadmap towards a more accurate prognostic   prediction and personali

  Abstract: null

  Address (URL):